Nanopublications LDF server

Matches in Nanopublications for { ?s ?p "[Signalling pathways known to be disrupted in UM include: (1) the retinoblastoma pathway, probably as a result of cyclin D1 overexpression; p53 signalling, possibly as a consequence of MDM2 overexpression; and the P13K/AKT and mitogen-activated protein kinase/extracellular signal-related kinase pathway pathways that are disturbed as a result of PTEN and GNAQ/11 mutations, respectively.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }

• NP203019.RAcYUtWWGUBn_647IwPANdMWOP7bIO4S8RyJtmCDmkhdU130_assertion description "[Signalling pathways known to be disrupted in UM include: (1) the retinoblastoma pathway, probably as a result of cyclin D1 overexpression; p53 signalling, possibly as a consequence of MDM2 overexpression; and the P13K/AKT and mitogen-activated protein kinase/extracellular signal-related kinase pathway pathways that are disturbed as a result of PTEN and GNAQ/11 mutations, respectively.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP203019.RAcYUtWWGUBn_647IwPANdMWOP7bIO4S8RyJtmCDmkhdU130_provenance.
• NP458738.RAnvKtjbygI7DuGrTwGxfKDMsQ6s_kPRz5XobcPuhOxEE130_assertion description "[Signalling pathways known to be disrupted in UM include: (1) the retinoblastoma pathway, probably as a result of cyclin D1 overexpression; p53 signalling, possibly as a consequence of MDM2 overexpression; and the P13K/AKT and mitogen-activated protein kinase/extracellular signal-related kinase pathway pathways that are disturbed as a result of PTEN and GNAQ/11 mutations, respectively.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP458738.RAnvKtjbygI7DuGrTwGxfKDMsQ6s_kPRz5XobcPuhOxEE130_provenance.
• NP697985.RAhZdYhlMlnqIzQ979nHi1dFrQWX2fnxwntBkn5_RigIo130_assertion description "[Signalling pathways known to be disrupted in UM include: (1) the retinoblastoma pathway, probably as a result of cyclin D1 overexpression; p53 signalling, possibly as a consequence of MDM2 overexpression; and the P13K/AKT and mitogen-activated protein kinase/extracellular signal-related kinase pathway pathways that are disturbed as a result of PTEN and GNAQ/11 mutations, respectively.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP697985.RAhZdYhlMlnqIzQ979nHi1dFrQWX2fnxwntBkn5_RigIo130_provenance.
• NP260702.RAwhokDl-0-XtZDO_31xM_BatTEfR33skmqmJxvARhwTM130_assertion description "[Signalling pathways known to be disrupted in UM include: (1) the retinoblastoma pathway, probably as a result of cyclin D1 overexpression; p53 signalling, possibly as a consequence of MDM2 overexpression; and the P13K/AKT and mitogen-activated protein kinase/extracellular signal-related kinase pathway pathways that are disturbed as a result of PTEN and GNAQ/11 mutations, respectively.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP260702.RAwhokDl-0-XtZDO_31xM_BatTEfR33skmqmJxvARhwTM130_provenance.
• NP232241.RA5911zx3ov6--VJoQ78uTAbuOQ-WqJKFRIJ5uP9jBBEw130_assertion description "[Signalling pathways known to be disrupted in UM include: (1) the retinoblastoma pathway, probably as a result of cyclin D1 overexpression; p53 signalling, possibly as a consequence of MDM2 overexpression; and the P13K/AKT and mitogen-activated protein kinase/extracellular signal-related kinase pathway pathways that are disturbed as a result of PTEN and GNAQ/11 mutations, respectively.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP232241.RA5911zx3ov6--VJoQ78uTAbuOQ-WqJKFRIJ5uP9jBBEw130_provenance.
• NP1034385.RAz7wHeDPGU8Mo9L7uKIdqB73bTa2kLKJhRDkhQ_yIzVE130_assertion description "[Signalling pathways known to be disrupted in UM include: (1) the retinoblastoma pathway, probably as a result of cyclin D1 overexpression; p53 signalling, possibly as a consequence of MDM2 overexpression; and the P13K/AKT and mitogen-activated protein kinase/extracellular signal-related kinase pathway pathways that are disturbed as a result of PTEN and GNAQ/11 mutations, respectively.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1034385.RAz7wHeDPGU8Mo9L7uKIdqB73bTa2kLKJhRDkhQ_yIzVE130_provenance.
• NP550667.RAMTgjlvKc-KXtYBTpGPACUcDqafeeJaQ31I154bw-fFU130_assertion description "[Signalling pathways known to be disrupted in UM include: (1) the retinoblastoma pathway, probably as a result of cyclin D1 overexpression; p53 signalling, possibly as a consequence of MDM2 overexpression; and the P13K/AKT and mitogen-activated protein kinase/extracellular signal-related kinase pathway pathways that are disturbed as a result of PTEN and GNAQ/11 mutations, respectively.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP550667.RAMTgjlvKc-KXtYBTpGPACUcDqafeeJaQ31I154bw-fFU130_provenance.
• NP654234.RALQ0XjBQYzD4e2-_KQi8SM-sGylrqo7n-5BAHD4fdUD8130_assertion description "[Signalling pathways known to be disrupted in UM include: (1) the retinoblastoma pathway, probably as a result of cyclin D1 overexpression; p53 signalling, possibly as a consequence of MDM2 overexpression; and the P13K/AKT and mitogen-activated protein kinase/extracellular signal-related kinase pathway pathways that are disturbed as a result of PTEN and GNAQ/11 mutations, respectively.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP654234.RALQ0XjBQYzD4e2-_KQi8SM-sGylrqo7n-5BAHD4fdUD8130_provenance.
• NP1034382.RAejDjxmj-zLbDkXK66AyWlZhvgBcnKBCJaVaqMdQsp84130_assertion description "[Signalling pathways known to be disrupted in UM include: (1) the retinoblastoma pathway, probably as a result of cyclin D1 overexpression; p53 signalling, possibly as a consequence of MDM2 overexpression; and the P13K/AKT and mitogen-activated protein kinase/extracellular signal-related kinase pathway pathways that are disturbed as a result of PTEN and GNAQ/11 mutations, respectively.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1034382.RAejDjxmj-zLbDkXK66AyWlZhvgBcnKBCJaVaqMdQsp84130_provenance.
• NP1034383.RAb-lMIg2RMl804z8Gpf3ATNAa7SFz-cOGajX-1VDKlQ0130_assertion description "[Signalling pathways known to be disrupted in UM include: (1) the retinoblastoma pathway, probably as a result of cyclin D1 overexpression; p53 signalling, possibly as a consequence of MDM2 overexpression; and the P13K/AKT and mitogen-activated protein kinase/extracellular signal-related kinase pathway pathways that are disturbed as a result of PTEN and GNAQ/11 mutations, respectively.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1034383.RAb-lMIg2RMl804z8Gpf3ATNAa7SFz-cOGajX-1VDKlQ0130_provenance.
• NP1034384.RAbYyZZy_SU_l2CqFaJ5XGjs6gkZc0MjIQpdc319UYl0o130_assertion description "[Signalling pathways known to be disrupted in UM include: (1) the retinoblastoma pathway, probably as a result of cyclin D1 overexpression; p53 signalling, possibly as a consequence of MDM2 overexpression; and the P13K/AKT and mitogen-activated protein kinase/extracellular signal-related kinase pathway pathways that are disturbed as a result of PTEN and GNAQ/11 mutations, respectively.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1034384.RAbYyZZy_SU_l2CqFaJ5XGjs6gkZc0MjIQpdc319UYl0o130_provenance.